Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes

The side effects of cisplatin, a widely used chemotherapeutic agent, include nephrotoxicity. Previous studies have reported that cisplatin induces ferroptosis and lipid peroxide accumulation. Ferroptosis, a type of regulated cell death, is characterized by iron-dependent lipid peroxidation. Although...

Full description

Bibliographic Details
Main Authors: Dong-Hyun Kim, Hoon-In Choi, Jung Sun Park, Chang Seong Kim, Eun Hui Bae, Seong Kwon Ma, Soo Wan Kim
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:Redox Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231722001549
_version_ 1811322934229204992
author Dong-Hyun Kim
Hoon-In Choi
Jung Sun Park
Chang Seong Kim
Eun Hui Bae
Seong Kwon Ma
Soo Wan Kim
author_facet Dong-Hyun Kim
Hoon-In Choi
Jung Sun Park
Chang Seong Kim
Eun Hui Bae
Seong Kwon Ma
Soo Wan Kim
author_sort Dong-Hyun Kim
collection DOAJ
description The side effects of cisplatin, a widely used chemotherapeutic agent, include nephrotoxicity. Previous studies have reported that cisplatin induces ferroptosis and lipid peroxide accumulation. Ferroptosis, a type of regulated cell death, is characterized by iron-dependent lipid peroxidation. Although previous studies have examined the regulation of ferroptosis in acute kidney injury (AKI), the regulatory mechanism of ferroptosis has not been elucidated. Here, the ability of activated farnesoid X receptor (FXR) to attenuate cisplatin-induced AKI through the regulation of ferroptosis was examined. FXR deficiency exhibited more ferroptosis responses, such as increase in lipid peroxidation, iron content and heme oxygenase 1 protein, and a decrease in glutathione/glutathione disulfide ratio and glutathione peroxidase 4 levels in HK2 cells and mice. Increased blood urea nitrogen, serum creatinine, and ferroptotic responses in the cisplatin-induced AKI mouse model were mitigated upon treatment with the FXR agonist GW4064 but were exacerbated in FXR knockout mice. RNA sequencing analysis revealed that ferroptosis-associated genes were novel targets of FXR. FXR agonist upregulated the expression of lipid and glutathione metabolism-related genes and downregulated cell death-related genes. Additionally, chromatin immunoprecipitation assays, using mice renal tissues, revealed that agonist-activated FXR could bind to its known target genes (Slc51a, Slc51b, Osgin1, and Mafg) and ferroptosis-related genes (Aifm2, Ggt6, and Gsta4). Furthermore, activated FXR-dependent MAFG, a transcriptional repressor, could bind to Hmox1, Nqo1, and Tf in the renal tissues of FXR agonist-treated mice. These findings indicate that activated FXR regulates the transcription of ferroptosis-related genes and protects against cisplatin-induced AKI.
first_indexed 2024-04-13T13:44:56Z
format Article
id doaj.art-a7e60101b6104e288050b1edfe111c8d
institution Directory Open Access Journal
issn 2213-2317
language English
last_indexed 2024-04-13T13:44:56Z
publishDate 2022-08-01
publisher Elsevier
record_format Article
series Redox Biology
spelling doaj.art-a7e60101b6104e288050b1edfe111c8d2022-12-22T02:44:31ZengElsevierRedox Biology2213-23172022-08-0154102382Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genesDong-Hyun Kim0Hoon-In Choi1Jung Sun Park2Chang Seong Kim3Eun Hui Bae4Seong Kwon Ma5Soo Wan Kim6Department of Internal Medicine, Chonnam National University Medical School, Gwangju, 61469, South KoreaDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju, 61469, South KoreaDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju, 61469, South KoreaDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju, 61469, South KoreaDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju, 61469, South KoreaDepartment of Internal Medicine, Chonnam National University Medical School, Gwangju, 61469, South KoreaCorresponding author. Department of Internal Medicine, Chonnam National University Medical School, 42 Jebongro, Gwangju, 61469, South Korea.; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, 61469, South KoreaThe side effects of cisplatin, a widely used chemotherapeutic agent, include nephrotoxicity. Previous studies have reported that cisplatin induces ferroptosis and lipid peroxide accumulation. Ferroptosis, a type of regulated cell death, is characterized by iron-dependent lipid peroxidation. Although previous studies have examined the regulation of ferroptosis in acute kidney injury (AKI), the regulatory mechanism of ferroptosis has not been elucidated. Here, the ability of activated farnesoid X receptor (FXR) to attenuate cisplatin-induced AKI through the regulation of ferroptosis was examined. FXR deficiency exhibited more ferroptosis responses, such as increase in lipid peroxidation, iron content and heme oxygenase 1 protein, and a decrease in glutathione/glutathione disulfide ratio and glutathione peroxidase 4 levels in HK2 cells and mice. Increased blood urea nitrogen, serum creatinine, and ferroptotic responses in the cisplatin-induced AKI mouse model were mitigated upon treatment with the FXR agonist GW4064 but were exacerbated in FXR knockout mice. RNA sequencing analysis revealed that ferroptosis-associated genes were novel targets of FXR. FXR agonist upregulated the expression of lipid and glutathione metabolism-related genes and downregulated cell death-related genes. Additionally, chromatin immunoprecipitation assays, using mice renal tissues, revealed that agonist-activated FXR could bind to its known target genes (Slc51a, Slc51b, Osgin1, and Mafg) and ferroptosis-related genes (Aifm2, Ggt6, and Gsta4). Furthermore, activated FXR-dependent MAFG, a transcriptional repressor, could bind to Hmox1, Nqo1, and Tf in the renal tissues of FXR agonist-treated mice. These findings indicate that activated FXR regulates the transcription of ferroptosis-related genes and protects against cisplatin-induced AKI.http://www.sciencedirect.com/science/article/pii/S2213231722001549Farnesoid X receptor (FXR)FerroptosisAcute kidney injury (AKI)Reactive oxidative stress (ROS)MAF bZIP transcription factor G (MAFG)
spellingShingle Dong-Hyun Kim
Hoon-In Choi
Jung Sun Park
Chang Seong Kim
Eun Hui Bae
Seong Kwon Ma
Soo Wan Kim
Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes
Redox Biology
Farnesoid X receptor (FXR)
Ferroptosis
Acute kidney injury (AKI)
Reactive oxidative stress (ROS)
MAF bZIP transcription factor G (MAFG)
title Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes
title_full Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes
title_fullStr Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes
title_full_unstemmed Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes
title_short Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes
title_sort farnesoid x receptor protects against cisplatin induced acute kidney injury by regulating the transcription of ferroptosis related genes
topic Farnesoid X receptor (FXR)
Ferroptosis
Acute kidney injury (AKI)
Reactive oxidative stress (ROS)
MAF bZIP transcription factor G (MAFG)
url http://www.sciencedirect.com/science/article/pii/S2213231722001549
work_keys_str_mv AT donghyunkim farnesoidxreceptorprotectsagainstcisplatininducedacutekidneyinjurybyregulatingthetranscriptionofferroptosisrelatedgenes
AT hooninchoi farnesoidxreceptorprotectsagainstcisplatininducedacutekidneyinjurybyregulatingthetranscriptionofferroptosisrelatedgenes
AT jungsunpark farnesoidxreceptorprotectsagainstcisplatininducedacutekidneyinjurybyregulatingthetranscriptionofferroptosisrelatedgenes
AT changseongkim farnesoidxreceptorprotectsagainstcisplatininducedacutekidneyinjurybyregulatingthetranscriptionofferroptosisrelatedgenes
AT eunhuibae farnesoidxreceptorprotectsagainstcisplatininducedacutekidneyinjurybyregulatingthetranscriptionofferroptosisrelatedgenes
AT seongkwonma farnesoidxreceptorprotectsagainstcisplatininducedacutekidneyinjurybyregulatingthetranscriptionofferroptosisrelatedgenes
AT soowankim farnesoidxreceptorprotectsagainstcisplatininducedacutekidneyinjurybyregulatingthetranscriptionofferroptosisrelatedgenes